Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers at the University of Oxford have proposed an evolutionary framework to understand why microbes living in the gut affect the brain and behaviour, published in Nature Reviews Microbiology.

Katerina Johnson (Department of Experimental Psychology) and Kevin Foster (Department of Zoology) assessed data from studies on the gut-brain axis to suggest how ‘that gut feeling’ evolved.

Research has shown that gut bacteria (especially species belonging to Lactobacillus and Bifidobacterium) can influence social behaviour, anxiety, stress and depressive-like behaviour. Katerina explained: “We know there are numerous possible mechanisms, including communication via the vagus nerve (major nerve linking the gut and brain), the immune system and hormonal changes, as well as the production of neuroactive chemicals by gut microbes. But why should we expect gut bacteria to affect behaviour at all?” In their paper, Johnson and Foster consider the evolutionary pressures that may have led to ‘that gut feeling’.

Find out more (University of Oxford website)

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.